Rubius Therapeutics, Inc. Debt to Equity Ratio 2018-2022 | RUBY
Current and historical debt to equity ratio values for Rubius Therapeutics, Inc. (RUBY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Rubius Therapeutics, Inc. debt/equity for the three months ending December 31, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-12-31 | $0.01B | $0.02B | 0.53 |
| 2022-09-30 | $0.13B | $0.04B | 3.67 |
| 2022-06-30 | $0.13B | $0.10B | 1.40 |
| 2022-03-31 | $0.13B | $0.14B | 0.98 |
| 2021-12-31 | $0.14B | $0.18B | 0.78 |
| 2021-09-30 | $0.14B | $0.22B | 0.61 |
| 2021-06-30 | $0.13B | $0.26B | 0.50 |
| 2021-03-31 | $0.13B | $0.30B | 0.43 |
| 2020-12-31 | $0.14B | $0.14B | 0.96 |
| 2020-09-30 | $0.14B | $0.17B | 0.80 |
| 2020-06-30 | $0.14B | $0.21B | 0.68 |
| 2020-03-31 | $0.11B | $0.24B | 0.48 |
| 2019-12-31 | $0.12B | $0.27B | 0.44 |
| 2019-09-30 | $0.13B | $0.31B | 0.41 |
| 2019-06-30 | $0.09B | $0.34B | 0.28 |
| 2019-03-31 | $0.07B | $0.37B | 0.19 |
| 2018-12-31 | $0.09B | $0.39B | 0.22 |
| 2018-09-30 | $0.04B | $0.41B | 0.10 |
| 2018-06-30 | $0.04B | $0.17B | 0.22 |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
